Opus Genetics, Inc. (IRD)
NASDAQ:IRD
Want to see IRD full AI Analyst Report?
Opus Genetics (IRD) Ownership Overview
14.18% Insiders
3.51% Mutual Funds
37.01% Other Institutional Investors
2.98% ETFs
42.31% Public Companies and Individual Investors
The ownership structure of Opus Genetics (IRD) stock is a mix of institutional, retail, and individual investors. Approximately 43.51% of the company’s stock is owned by Institutional Investors, 14.18% is owned by Insiders, and 42.31% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 20, 2026 | xxxxxxxxxxxxx | $7395000 | |
Apr 27, 2026 | xxxxxxxxxxxxx | $39068 | |
Apr 27, 2026 | xxxxxxxxxxxxx | $24518 | |
Apr 27, 2026 | xxxxxxxxxxxxx | $39143 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $8353081 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $4550000 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $6160837 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,792,171 | Insider | 4.66% | 16,533,866 | |
| 2,385,445 | Institution | 2.93% | 10,400,540 | |
| 2,366,467 | Institution | 2.91% | 10,317,796 | |
| 2,098,797 | Insider | 2.58% | 9,150,755 | |
| 1,835,842 | Institution | 2.26% | 8,004,271 | |
| 1,741,344 | Insider | 2.14% | 7,592,260 | |
| 1,354,030 | Institution | 1.66% | 5,903,571 | |
| 1,000,000 | Institution | 1.23% | 4,360,000 | |
| 711,535 | Insider | 0.87% | 3,102,293 | |
| 592,158 | Insider | 0.73% | 2,581,809 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,366,467 | Institution | 2.91% | 10,317,796 | |
| 422,258 | Institution | 0.52% | 1,841,045 | |
| 38,271 | Institution | 0.05% | 166,862 | |
| 26,271 | Institution | 0.03% | 114,542 | |
| 7,385 | Institution | <0.01% | 32,199 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,894,478 | Institution | 2.33% | 9,680,783 | |
| 490,967 | Institution | 0.60% | 2,508,841 | |
| 42,065 | Institution | 0.05% | 176,673 |
FAQ
Who Owns Opus Genetics, Inc. (IRD)?
According to the latest TipRanks data, approximately 37.01% of the company's stock is held by institutional investors, 14.18% is held by insiders, and 42.31% is held by retail investors.
What percentage of Opus Genetics, Inc. (IRD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.01% of Opus Genetics, Inc. (IRD) stock is held by institutional investors.
What percentage of Opus Genetics, Inc. (IRD) stock is held by retail investors?
According to the latest TipRanks data, approximately 42.31% of Opus Genetics, Inc. (IRD) stock is held by retail investors.
Who owns the most shares of Opus Genetics, Inc. (IRD)?
Foundation Fighting Blindness Retinal Degeneration owns the most shares of Opus Genetics, Inc. (IRD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.